Induce Biologics
Induce biologics uses a process called nmp™ to unlock growth factors in bone and make them available for promoting natural bone regeneration.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | $2.6m | Late VC | |
| Total Funding | 000k | ||
Induce Biologics specializes in developing bioimplants that utilize Natural Matrix Protein (NMP) technology to enhance natural bone regeneration. The company serves clients in the orthopedic and dental sectors, providing solutions for spine, foot, ankle, and dental applications. Operating in the regenerative medicine market, Induce Biologics employs a business model focused on the sale of bioimplant products to healthcare providers and distributors. Revenue is generated through direct sales and distribution partnerships. The core technology, NMP, unlocks growth factors naturally found in bone, making them bioavailable and promoting effective bone healing. This innovative approach differentiates Induce Biologics from traditional methods that limit osteoinductivity by locking growth factors in the bone matrix. The company's leadership boasts extensive experience in regenerative medicine, further solidifying its position in the market.
Keywords: bioimplants, Natural Matrix Protein, bone regeneration, orthopedic, dental, regenerative medicine, NMP technology, healthcare providers, distributors, osteoinductivity.